Elizabeth A. Handorf

Affiliations: 
2012 Biostatistics University of Pennsylvania, Philadelphia, PA, United States 
Google:
"Elizabeth Handorf"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Handorf EA, Smaldone MC, Movva S, et al. (2022) Analysis of survival data with nonproportional hazards: A comparison of propensity-score-weighted methods. Biometrical Journal. Biometrische Zeitschrift. e202200099
Madnick D, Handorf E, Ortiz A, et al. (2020) Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients. Journal of Gastrointestinal Oncology. 11: 633-643
Zimmaro LA, Deng M, Handorf E, et al. (2020) Understanding benefit finding among patients with colorectal cancer: a longitudinal study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Lynch SM, Handorf E, Sorice KA, et al. (2020) The effect of neighborhood social environment on prostate cancer development in black and white men at high risk for prostate cancer. Plos One. 15: e0237332
Wong JK, Handorf E, Lee D, et al. (2020) Toxicity and outcomes in older versus younger patients treated with trimodality therapy for locally advanced rectal cancer. Journal of Geriatric Oncology
Jain R, Handorf E, Khare V, et al. (2020) Impact of Baseline Nutrition and Exercise Status on Toxicity and Outcomes in Phase I and II Oncology Clinical Trial Participants. The Oncologist. 25: 161-169
Agrawal S, Meeker CR, Aggarwal S, et al. (2020) HSR20-076: Provider Versus Patient Reported Outcomes (PROs) in Colorectal Cancer (CRC) Patients (pts) Undergoing Systemic Therapy (Ctx): A Real World Experience Journal of the National Comprehensive Cancer Network. 18
Lewis B, Meeker CR, Handorf E, et al. (2020) HSR20-093: Psychosocial Support in Older Patients With Metastatic Breast Cancer (MBC) Treated at Community Centers Journal of the National Comprehensive Cancer Network. 18
Strother M, Kutikov A, Lewis B, et al. (2020) Neoadjuvant cisplatin-based chemotherapy in patients with ureteral obstruction secondary to muscle invasive bladder cancer. Journal of Clinical Oncology. 38: 523-523
Walzer E, Deng M, Handorf EA, et al. (2020) Neoadjuvant therapy (NAT) and its role for pancreatic adenocarcinoma (PC) in the current era: Institutional experience. Journal of Clinical Oncology. 38: 672-672
See more...